Fodders
2019
2019
- What Really Helps Chronic Pain Patients By Judy Butler, Research Fellow (February 2019)
- Industry's Voice, Pain Patient's Face By Judy Butler, Research Fellow (March 2019)
- Who's Really Advocating for Pain Patients By Judy Butler, Research Fellow (April 2019)
- Preventing a new generation of opioid “legacy patients" By Judy Butler, Research Fellow (May 2019)
- Highlights from the Johnson & Johnson Opioids Verdict By Judy Butler, Research Fellow (August/September 2019)
- Disinfecting Pharma with Sunshine: The Case for Bringing Documents to Light By Judy Butler, Research Fellow (October 2019)
- When Sunshine Doesn't Cast Enough Light By Judy Butler, Research Fellow (November 2019)
- In Opioid Cases, Look to Tobacco Litigation for Guidance By Adriane Fugh-Berman and Robert Weissman (December 2019)
2018
2018
- Purdue's Latest PR Move By Judy Butler, Research Fellow (April 2018)
- Pharma and the NIH: Innocence By Association? By Judy Butler, Research Fellow and Dr. Adriane Fugh-Berman (May 2018)
- Subsys Sales, from Salacious to Scammy By Judy Butler, Research Fellow (July 2018)
- A Million Ways to Market A Pill By Judy Butler, Research Fellow (August 2018)
- Greater Decline in Opioid Prescribing After CDC Guidelines Released By Judy Butler, Research Fellow (October 2018)
- Make Punishment Personal By Judy Butler, Research Fellow (November 2018)
- An opioid treatment for depression nixed by FDA advisory committee By Ben Goodwin (December 2018)